# OLB Group, Inc.: overview

OLB · Nasdaq · CIK 1314196 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/olb.md) · [Financials](/companies/olb/financials.md) · [Filings](/companies/olb/filings.md) · [Insiders](/companies/olb/insiders.md)

Latest reported revenue: [$1.3m](/filings/0001185185-26-003553.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001185185-26-003553).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,084](/filings/0001213900-25-110806.md) | [2,738 d](/filings/0001213900-26-037906.md) | [2,322](/filings/0001213900-26-058054.md) | [2,267](/filings/0001185185-26-003553.md) | [2,313](/filings/0001213900-25-110806.md) | [1,775 d](/filings/0001213900-26-037906.md) | [1,656](/filings/0001213900-26-058054.md) | [1,279](/filings/0001185185-26-003553.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(52.9%)](/filings/0001213900-25-110806.md) | [(166.0%) d](/filings/0001213900-26-037906.md) | [(36.6%)](/filings/0001213900-26-058054.md) | [(74.8%)](/filings/0001185185-26-003553.md) | [(49.1%)](/filings/0001213900-25-110806.md) | [(83.7%) d](/filings/0001213900-26-037906.md) | [(76.7%)](/filings/0001213900-26-058054.md) | [(98.5%)](/filings/0001185185-26-003553.md) |
| Net margin | % | [(52.9%)](/filings/0001213900-24-098565.md) | [(166.1%) d](/filings/0001213900-25-032064.md) | [(46.9%)](/filings/0001213900-25-044180.md) | [(93.7%)](/filings/0001185185-26-003553.md) | [(50.8%)](/filings/0001213900-25-110806.md) | [(83.7%) d](/filings/0001213900-26-037906.md) | [(65.1%)](/filings/0001185185-26-003553.md) | [(82.5%)](/filings/0001185185-26-003553.md) |
| Diluted EPS | $ per share | [(0.92)](/filings/0001213900-25-110806.md) | not reported | [(0.47)](/filings/0001213900-26-058054.md) | [(0.66)](/filings/0001185185-26-003553.md) | [(0.13)](/filings/0001213900-25-110806.md) | not reported | [(0.08)](/filings/0001213900-26-058054.md) | [(0.08)](/filings/0001185185-26-003553.md) |
| Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [16.7](/filings/0001213900-23-024330.md) | [30.4](/filings/0001213900-24-032767.md) | [30.6](/filings/0001213900-25-032064.md) | [12.8](/filings/0001213900-26-037906.md) | [8.7](/filings/0001213900-26-037906.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(28.5%)](/filings/0001213900-23-024330.md) | [(26.9%)](/filings/0001213900-24-032767.md) | [(76.8%)](/filings/0001213900-25-032064.md) | [(90.9%)](/filings/0001213900-26-037906.md) | [(59.5%)](/filings/0001213900-26-037906.md) |
| Net margin | % | [(29.8%)](/filings/0001213900-23-024330.md) | [(25.6%)](/filings/0001213900-24-032767.md) | [(75.8%)](/filings/0001213900-25-032064.md) | [(87.4%)](/filings/0001213900-25-032064.md) | [(67.7%)](/filings/0001213900-26-037906.md) |
| Diluted EPS | $ per share | not reported | [(0.56)](/filings/0001213900-24-032767.md) | [(15.33)](/filings/0001213900-25-032064.md) | [(6.10)](/filings/0001213900-26-037906.md) | [(1.74)](/filings/0001213900-26-037906.md) |
| Free cash flow | $m | [(13.1)](/filings/0001213900-23-024330.md) | [(3.5)](/filings/0001213900-24-032767.md) | [0.8](/filings/0001213900-25-032064.md) | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:ProfitLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/olb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ARMISTICE CAPITAL, LLC](/funds/1601086.md) | 2026-06-30 | $583.2k | 1,531,152 |  | New +1,531,152 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $35.2k | 92,502 |  | Added +73,957 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $31.6k | 82,849 |  | Added +75,099 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $24.3k | 63,804 |  | Reduced −61,621 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $11.7k | 30,668 |  | New +30,668 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $4.7k | 12,416 |  | Reduced −9,237 |
| [IFP Advisors, Inc](/funds/1641866.md) | 2026-06-30 | $3.4k | 9,000 |  | Added +4,000 |
| [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $1.9k | 4,966 |  | Reduced −1 |
| [Marshall & Sterling Wealth Advisors Inc.](/funds/2056315.md) | 2026-06-30 | $343 | 900 |  | Unchanged |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $114 | 300 |  | Unchanged |

## Recent filings

[All 329 filings](/companies/olb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:30 ET | [DEF 14A](/filings/0001185185-26-004974.md) | Proxy statement, period 2026-11-19 | 0001185185-26-004974 |
| 2026-09-10 | 21:49 ET | [S-1](/filings/0001185185-26-003902.md) | Registration statement | 0001185185-26-003902 |
| 2026-08-14 | 20:32 ET | [10-Q](/filings/0001185185-26-003553.md) | Quarterly report, period 2026-06-30 | 0001185185-26-003553 |
| 2026-08-14 | 20:30 ET | [10-K/A](/filings/0001185185-26-003551.md) | Annual report, amended, period 2025-12-31 | 0001185185-26-003551 |
| 2026-08-12 | 20:15 ET | [8-K](/filings/0001185185-26-003446.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001185185-26-003446 |
| 2026-05-18 | 23:38 ET | [10-Q](/filings/0001213900-26-058054.md) | Quarterly report, period 2026-03-31 | 0001213900-26-058054 |
| 2026-04-16 | 21:09 ET | [S-1](/filings/0001213900-26-044715.md) | Registration statement | 0001213900-26-044715 |
| 2026-04-01 | 01:41 ET | [10-K](/filings/0001213900-26-037906.md) | Annual report, period 2025-12-31 | 0001213900-26-037906 |
| 2026-02-23 | 22:00 ET | [8-K](/filings/0001213900-26-019383.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-019383 |
| 2026-02-03 | 22:15 ET | [8-K](/filings/0001213900-26-011584.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-011584 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-037906.md), filed Apr 1, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/cbf5d79a-42bf-489d-afc2-cfe7122e1452)

## About the filer

- CIK: 1314196
- Tickers: OLB
- Exchange: Nasdaq
- SIC code: 7389 Services-Business Services, NEC
- State of incorporation: DE
- Filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.